aTyr Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell aTyr Pharma and other ETFs, options, and stocks.

About ATYR

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1.

CEO

Sanjay S. Shukla

CEOSanjay S. Shukla

Employees

Employees59

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2005

Founded2005

Employees

Employees59

ATYR Key Statistics

Market cap

461.49M

Market cap461.49M

Price-Earnings ratio

-6.44

Price-Earnings ratio-6.44

Dividend yield

—

Dividend yield—

Average volume

4.84M

Average volume4.84M

High today

$5.45

High today$5.45

Low today

$5.12

Low today$5.12

Open price

$5.38

Open price$5.38

Volume

3.79M

Volume3.79M

52 Week high

$5.98

52 Week high$5.98

52 Week low

$1.51

52 Week low$1.51

Analyst ratings

100%

of 11 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own ATYR. This list is generated using Robinhood data, and it’s not a recommendation.

Rocket Lab Corporation

aTyr Pharma

Why Robinhood?

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. Show more

ATYR Key Statistics

Analyst ratings

100%

People also own

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1.